Advertisement

Topics

Biotechnology Value Fund, L.P. Company Profile

01:32 EST 21st November 2017 | BioPortfolio


News Articles [295 Associated News Articles listed on BioPortfolio]

Big Biotech ETF Bounce Looks for More Upside

The iShares Nasdaq Biotechnology ETF , the largest biotechnology exchange traded fund by assets, is up more than 11% over just the past month. Resurgent biotechnology stocks and ETFs have been fueled ...

Biotech Etf Ibb On Pace For Best Weekly Gain 7 Months

A popular fund used to invest in the biotechnology sector on Thursday was on track for its best weekly gain in seven months, according to FactSet data. The iShares Nasdaq Biotechnology ETF was up 1.3%...

Syndax nets $24.8mm from RDO to Biotechnology Value Fund

Syndax Pharmaceuticals Inc. (oncology) netted $24.8mm through a registered direct offering to Biotechnology Value Fund of 2mm common shares at $12.37 (about market average). Funds will support develop...

Week In Review: C-Bridge Raises $400 Million For Second China Healthcare Fund

Bridge Capital, a China private equity firm with a life science focus, closed its second fund, C-Bridge Healthcare Fund II, at its $400 million cap. C-Bridge plans to invest in late-stage companies in...

Your Daily Pharma Scoop: The First Trust NYSE Arca Biotechnology...

This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. First Tr...

#news #biotech Canaan unveils $800M fund for fresh wave of biotech bets

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Canaan unveils $800M fund for fresh wave of biotech bets .Canaan has put toge...

Cantab, MCCC To Fund Phogen Biotechnology For Third Year

Cantab Pharmaceuticals (Cambridge, UK) and Marie Curie Cancer Care (MCCC; London) will renew their financial support for Phogen (Cambridge, UK), a biotechnology company, for an additional year...

Immunomic Offers Travel Fund For Clinical Trial Patients

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company is proud to announce a travel fund for patients enrolled in a Ph...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Bio-active anti-aging [S.I.P.R.E.S. SRL]

Bio-Active Anti-Aging Cream Multi-Protection Daily Renewal SPF 15 Advanced Double Lifting Effect

Biodynamic skin [S.I.P.R.E.S. SRL]

Biodynamic Skin Solution

PubMed Articles [323 Associated PubMed Articles listed on BioPortfolio]

Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics.

Policies such as the Cancer Drugs Fund in England assumed a societal preference to fund cancer care relative to other conditions, even if that resulted in lower health gain for the population overall.

A trauma-informed examination of the hardships experienced by abortion fund patients in the United States.

Researchers describe hardships experienced by abortion patients, examining administrative health cases from 2010-2015 in the United States. All patients received financial assistance from an abortion ...

Editorial overview: Systems biology for biotechnology.

In memory of Professor Brian F. C. Clark: Tribute by Mike Taussig, Editor in Chief, New Biotechnology.

Editorial overview: Pharmaceutical biotechnology.

Clinical Trials [33 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Stivarga Real Life Evidence in Hungary

The study aims to evaluate use of regorafenib in clinical practice in Hungary. The study should provide information about clinical characteristics of Hungarian regorafenib patients as well...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Liprotamase powder is a non-porcine, soluble and stable mixture of biotechnology-derived lipase, protease, and amylase digestive enzymes. The purpose of the present study is to to evaluate...

Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand

Since 2004, the Thai Ministry of Public Health has massively scaled up antiretroviral treatment programs to provide therapy to more than 80,000 patients with partial support of the Global ...

Companies [1317 Associated Companies listed on BioPortfolio]

BioPharma Fund

BioPharma Fund is an investment fund that invests in shares of medical biotechnology companies. Biotechnology companies are developing new drugs for many diseases such as cancer, heart disease, diabet...

Hatchtech

Hatchtech Pty Ltd is a venture-backed specialty pharmaceutical product company that is developing technology for the control of invertebrate pests. The Company’s investors in...

Longwood Founders Fund, L.P.

Longwood Founders Fund is a healthcare venture capital firm that founds, manages, and builds biotechnology companies. Longwood’s mission is to identify technologies and to fo...

JDRF T1D Fund

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund accelerating life changing solutions to treat, prevent, and cure type 1 diabetes (T1D) through catalytic ...

Biotechnology Value Fund, L.P.

More Information about "Biotechnology Value Fund, L.P." on BioPortfolio

We have published hundreds of Biotechnology Value Fund, L.P. news stories on BioPortfolio along with dozens of Biotechnology Value Fund, L.P. Clinical Trials and PubMed Articles about Biotechnology Value Fund, L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotechnology Value Fund, L.P. Companies in our database. You can also find out about relevant Biotechnology Value Fund, L.P. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record